01/07/2024
๐๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐๐โ๐ ๐๐๐๐๐๐๐
๐๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐ ๐๐จ๐ง๐ญ๐๐ง๐ญ: https://surf-theory-ff5.notion.site/CANNABINOID-IN-PARKINSON-S-DISEASE-85d1e662344149b78fff2f3cc2faf953?pvs=74
๐ Parkinson disease is a neurodegenerative disorder that mostly presents in later life with generalized slowing of movements (bradykinesia) and at least one other symptom of resting tremor or rigidity.
Other associated features are a loss of smell, sleep dysfunction, mood disorders, excess salivation, constipation, and excessive periodic limb movements in sleep (REM behavior disorder).
๐๐๐ญ๐ก๐จ๐ฉ๐ก๐ฒ๐ฌ๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐ข๐ง ๐๐๐ซ๐ค๐ข๐ง๐ฌ๐จ๐ง'๐ฌ ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐: dopamine deficiency of striatum receptors โ Decrease in "disinhibition" โ Increasing inhibition of motor skills โ Bradykinesis
๐ด๐๐๐๐๐๐โ๐๐๐: ๐ ๐๐๐-๐ ๐๐๐๐๐ก๐๐ฃ๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐ก ๐คโ๐๐โ ๐๐๐ก๐๐ฃ๐๐ก๐๐ ๐๐๐กโ ๐ท2-๐๐๐๐ ๐๐๐, ๐ก๐ ๐ ๐๐ข๐โ ๐๐๐ ๐ ๐๐ ๐๐ฅ๐ก๐๐๐ก, ๐ท1-๐๐๐๐ ๐๐๐๐๐๐ก๐๐๐ . ๐ผ๐ก ๐๐๐ ๐ ๐๐๐ก๐ ๐๐ ๐๐ ๐๐๐ก๐๐๐๐๐๐ ๐ก ๐๐ 5-๐ป๐2 ๐๐๐ ฮฑ-๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ก๐๐๐ ๐ค๐๐กโ โ๐๐โ ๐๐๐๐๐๐๐ก๐ฆ. ๐โ๐ ๐๐๐๐๐๐ข๐๐ ๐๐ โ๐๐ ๐ก๐๐๐๐๐๐๐๐ฆ ๐ ๐๐๐๐โ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐ก๐๐๐ ๐๐๐๐๐ข๐๐ก ๐๐๐๐ ๐๐ฆ ๐๐๐๐๐๐๐ ๐๐๐๐โ๐๐๐ ๐ค๐๐กโ ๐๐๐๐๐๐๐ก๐๐๐ก๐๐ ๐๐๐๐, โ๐๐๐๐ ๐กโ๐ -๐๐๐๐โ๐๐๐ ๐ ๐ข๐๐๐๐ฅ. ๐ถ๐๐๐ก๐๐๐๐ฆ ๐ก๐ ๐๐ก๐ ๐๐๐๐, ๐๐๐๐๐๐๐โ๐๐๐ ๐๐๐๐ ๐๐๐ก ๐๐๐ก๐ข๐๐๐๐ฆ ๐๐๐๐ก๐๐๐ ๐๐๐๐โ๐๐๐ ๐๐ ๐๐ก๐ ๐ ๐๐๐๐๐ก๐๐, ๐๐๐ ๐๐๐๐ ๐๐ก ๐๐๐๐ ๐ก๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐ก๐๐๐ .
# # ๐๐ฉ๐ฉ๐ซ๐จ๐๐๐ก ๐ญ๐จ ๐๐๐ง๐ง๐๐๐ข๐ง๐จ๐ข๐
Cannabis has two main active ingredients Tetrahydrocannabinol THC and cannabidiol (CBD) are obtained from the h**p plant and usually consumed inhaled as twisted ci******es (joints) or orally, e.g. in the form of biscuits (so-called space cookies).
Binding to the specific cannabinoid receptors CB1, CB2 โ E.a. Inhibition of a GABAergic interneuron โ Inhibition of the inhibitory effect on downstream dopaminergic neurons โ Increase in dopamine secretion in the nucleus accumbens of the mesolimbic reward system
**Ma*****na** consists of 85 phytocannabinoids, from which cannabidiol (CBD) and tetrahydrocannabinol (THC) are the main constituents. CBD and THC are responsible for the medicinal effects of ma*****na
- **CBD** is non-psychoactive and is known to have hypnotic, anxiolytic, antipsychotic, and neuroprotective effects
- **THC** is the main component responsible for psychotropic effects of cannabis, and it acts via two types of G protein-coupled receptors, known as cannabinoid type 1 (CB1) and type 2 (CB2)
**Endocannabinoids** are produced in the body and help regulate memory, pleasure, concentration, thinking, movement, sensory and time perception, appetite, and pain. They act on CB1 and CB2 receptors. The main endocannabinoids are **anandamide** and **2-arachidonoyl glycerol**.
Globus pallidus and substantia nigra are major brain areas involved in the control of movements and contain the highest densities of CB1 receptors, as well as the highest levels of anandamide .
Dopaminergic D2 receptors regulate anandamide synthesis in the striatum which gives inhibitory feedback to dopamine-induced motor activity